Overview

Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of anidulafungin versus fluconazole for the prevention of fungal diseases in liver transplant recipients
Phase:
Phase 4
Details
Lead Sponsor:
University of Pittsburgh
Treatments:
Anidulafungin
Antifungal Agents
Echinocandins
Fluconazole